Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Drug Prices To Be Monitored By HHS Under Medicaid Fraud Settlement

Executive Summary

Bayer will provide states and the federal government with the average selling prices of its drugs to help them set reasonable reimbursement rates under a tentative settlement agreement with the Justice Department.

You may also be interested in...



AWP Settlements Unlikely To Resolve Pricing Issue, State Fraud Chief Says

Federal health care fraud prosecutions will not be sufficient to resolve the issues surrounding AWP price reporting, National Association of State Medicaid Fraud Control Units President Christopher Abruzzo told the 340B Coalition annual conference in Washington, D.C. July 16

AWP Settlements Unlikely To Resolve Pricing Issue, State Fraud Chief Says

Federal health care fraud prosecutions will not be sufficient to resolve the issues surrounding AWP price reporting, National Association of State Medicaid Fraud Control Units President Christopher Abruzzo told the 340B Coalition annual conference in Washington, D.C. July 16

GSK, Bayer Will Audit Sales Contracts Under “Best Price” Rebate Settlement

Bayer will use an outside auditing firm to review its payments to managed care companies to ensure that the company is not disguising rebate payments

Related Content

UsernamePublicRestriction

Register

LL1135866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel